Treatment of diabetes with a glucokinase gene

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/54 (2006.01) A61K 31/70 (2006.01) A61K 35/12 (2006.01) A61K 35/34 (2006.01) A61K 35/407 (2006.01) A61K 48/00 (2006.01) C12N 5/10 (2006.01) C12N 9/12 (2006.01) C12N 15/85 (2006.01)

Patent

CA 2236332

Process for treating a diabetic patient. The process comprises administering to the patient a DNA segment which includes a glucokinase gene and a promotor sequence. In the DNA segment, the promotor sequence is operatively linked to the glucokinase gene and is efficient for the expression of a therapeutically efficient quantity of glucokinase in the diabetic patient.

Procédé de traitement d'un patient diabétique. Le procédé consiste à administrer au patient un segment d'ADN qui comprend un gène de glucokinase et une séquence de promoteur. Dans le segment d'ADN, la séquence de promoteur est liée de manière effective au gène de glucokinase et est efficace pour l'expression d'une quantité thérapeutiquement efficace de glucokinase chez le patient souffrant de diabète.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of diabetes with a glucokinase gene does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of diabetes with a glucokinase gene, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of diabetes with a glucokinase gene will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1832922

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.